How lenacapavir boosts Nigeria’s HIV Fight, expands Prevention Reach —Expert
By Ojoma Akor Nigeria’s drive to end HIV by 2030 would gain critical ground with the introduction of lenacapavir, a long-acting prevention drug expected to widen access and close persistent gaps among high-risk populations, a public health expert, Dr. Adebayo Opeyemi, has said. He said the introduction of lenacapavir marks a major step in Nigeria’s…

